Abstract
Ventricular arrhythmias are common in the setting of acute myocardial infarction (AMI). In todays era of reperfusion therapy, anti-arrhythmic medications, and Implantable Cardioverter Defibrillators (ICDs), an understanding of these arrhythmias and the prognosis of patients with these arrhythmias is essential in determining the proper treatment strategy. In general, ventricular arrhythmias occurring in the first 48 hours (early) following admission for AMI do not predict an increased risk of arrhythmias in follow-up. While early sustained ventricular tachycardia and ventricular fibrillation predict increased in-hospital mortality, the medium and long-term mortality is comparable to control populations in most studies. In contrast, ventricular arrhythmias occurring after 48 hours (late) generally predict an increased risk of arrhythmias and sudden cardiac death. This review focuses on the different ventricular arrhythmias which occur in both the early and late stages following myocardial infarction. Special attention is made to the incidence and prognosis of these arrhythmias, and how this relates to current treatment recommendations.
Keywords: Ventricular tachycardia, ventricular fibrillation, myocardial infarction
Current Cardiology Reviews
Title: Prognosis and Treatment of Ventricular Arrhythmias Following Myocardial Infarction
Volume: 3 Issue: 1
Author(s): Douglas W. Laidlaw, Munther K. Homoud, Jonathan Weinstock, N. A. Mark Estes III and Mark S. Link
Affiliation:
Keywords: Ventricular tachycardia, ventricular fibrillation, myocardial infarction
Abstract: Ventricular arrhythmias are common in the setting of acute myocardial infarction (AMI). In todays era of reperfusion therapy, anti-arrhythmic medications, and Implantable Cardioverter Defibrillators (ICDs), an understanding of these arrhythmias and the prognosis of patients with these arrhythmias is essential in determining the proper treatment strategy. In general, ventricular arrhythmias occurring in the first 48 hours (early) following admission for AMI do not predict an increased risk of arrhythmias in follow-up. While early sustained ventricular tachycardia and ventricular fibrillation predict increased in-hospital mortality, the medium and long-term mortality is comparable to control populations in most studies. In contrast, ventricular arrhythmias occurring after 48 hours (late) generally predict an increased risk of arrhythmias and sudden cardiac death. This review focuses on the different ventricular arrhythmias which occur in both the early and late stages following myocardial infarction. Special attention is made to the incidence and prognosis of these arrhythmias, and how this relates to current treatment recommendations.
Export Options
About this article
Cite this article as:
Laidlaw W. Douglas, Homoud K. Munther, Weinstock Jonathan, Mark Estes III A. N. and Link S. Mark, Prognosis and Treatment of Ventricular Arrhythmias Following Myocardial Infarction, Current Cardiology Reviews 2007; 3 (1) . https://dx.doi.org/10.2174/157340307779940004
DOI https://dx.doi.org/10.2174/157340307779940004 |
Print ISSN 1573-403X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6557 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Association of Lower Adiponectin Plasma Levels, Increased Age and Smoking with Subclinical Atherosclerosis in Patients with HIV-1 Infection
Current HIV Research Chronic Diseases and COVID-19: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Renal Function, Albumin-Creatinine Ratio and Pulse Wave Velocity Predict Silent Coronary Artery Disease and Renal Outcome in Type 2 Diabetic and Prediabetic Subjects
Current Hypertension Reviews Neuroimmunomodulation and Aging: A Role for Transferrin and the Hypothalamus/Thymus Axis
Current Aging Science Retracted: Tocotrienols and its Role in Cardiovascular Health- a Lead for Drug Design
Current Pharmaceutical Design Structure of Atherosclerotic Plaques in Different Vascular Territories: Clinical Relevance
Current Vascular Pharmacology Intracranial MR Dynamics in Clinically Diagnosed Alzheimers Disease: The Emerging Concept of “Pulse Wave Encephalopathy”
Current Alzheimer Research Towards the Design of Social Media to Promote Physical Activity
Recent Advances in Communications and Networking Technology (Discontinued) Vascular Stiffness: Measurements, Mechanisms and Implications
Current Vascular Pharmacology Biomarkers of Alcohol Consumption in Body Fluids - Possibilities and Limitations of Application in Toxicological Analysis
Current Medicinal Chemistry The Assessment of Platelet Activation in Antiplatelet Drug Development
Current Medicinal Chemistry Lipoic Acid as a Potential Therapy for Chronic Diseases Associated with Oxidative Stress
Current Medicinal Chemistry Cognitive Function and the Ageing Process: The Peculiar Role of Mild Thyroid Failure
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Adipose Tissue as a Source of Vasoactive Factors
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Role of Endothelin in Uteroplacental Circulation and Fetal Vascular Function
Current Vascular Pharmacology Combined Dyslipidemia: Should the Focus be LDL Cholesterol or Atherogenic Dyslipidemia?
Current Pharmaceutical Design A Ligand-Based Approach to Mining the Chemogenomic Space of Drugs
Combinatorial Chemistry & High Throughput Screening Cancer Treatment-Induced Cardiotoxicity: a Cardiac Stem Cell Disease?
Cardiovascular & Hematological Agents in Medicinal Chemistry Isolated Perioperative Hypertension: Clinical Implications & Contemporary Treatment Strategies
Current Hypertension Reviews Vascular Pharmacotherapy and Dementia
Current Vascular Pharmacology